April 26, 2023
Life Sciences | Tea Leaves
  • Yesterday, senate health committee leaders Bernie Sanders and Bill Cassidy announced an agreement on a bipartisan package to increase access to generic drugs and increase transparency required of pharmacy benefit managers (PBMs).The package includes four bills that would increase oversight of the Food and Drug Administration’s citizen petition process, reduce incentives for generic drug manufacturers to delay putting their drugs on the market, revise laws governing orphan drug exclusivities in response to a 2021 court ruling, and make a variety of reforms to how pharmacy benefit managers operate. (Articles here, here, and here)